Viva Biotech Holdings is a Shanghai-based biotechnology company and corporate venture investor using an equity-for-service incubation model alongside drug-discovery, CRO and CDMO capabilities. It backs and incubates high-potential life sciences startups, with early-stage venture activity in U.S. therapeutics companies across biotechnology, pharmaceuticals and oncology. Founders developing small-molecule, biologics or drug-development platforms are relevant fits when seeking strategic capital paired with sector infrastructure and technical support.